HighMark Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.2K | Buy |
188
+24
| +15% | +$2.58K | 0.01% | 222 |
|
|
2025
Q1 | $16.5K | Sell |
164
-6
| -4% | -$605 | 0.01% | 215 |
|
|
2024
Q4 | $15.2K | Sell |
170
-11
| -6% | -$982 | 0.01% | 235 |
|
|
2024
Q3 | $15.2K | Sell |
181
-93
| -34% | -$7.79K | 0.01% | 237 |
|
|
2024
Q2 | $21.1K | Sell |
274
-25
| -8% | -$1.93K | 0.01% | 198 |
|
|
2024
Q1 | $20.5K | Sell |
299
-12
| -4% | -$822 | 0.01% | 197 |
|
|
2023
Q4 | $18K | Hold |
311
| – | – | 0.01% | 200 |
|
|
2023
Q3 | $16.4K | Buy |
311
+103
| +50% | +$5.44K | 0.01% | 198 |
|
|
2023
Q2 | $11.3K | Hold |
208
| – | – | 0.01% | 244 |
|
|
2023
Q1 | $10.4K | Buy |
208
+43
| +26% | +$2.15K | 0.01% | 295 |
|
|
2022
Q4 | $7.64K | Buy |
165
+120
| +267% | +$5.55K | 0.01% | 291 |
|
|
2022
Q3 | $2K | Hold |
45
| – | – | ﹤0.01% | 417 |
|
|
2022
Q2 | $2K | Hold |
45
| – | – | ﹤0.01% | 424 |
|
|
2022
Q1 | $2K | Hold |
45
| – | – | ﹤0.01% | 432 |
|
|
2021
Q4 | $2K | Hold |
45
| – | – | ﹤0.01% | 437 |
|
|
2021
Q3 | $2K | Hold |
45
| – | – | ﹤0.01% | 438 |
|
|
2021
Q2 | $2K | Hold |
45
| – | – | ﹤0.01% | 449 |
|
|
2021
Q1 | $2K | Sell |
45
-146
| -76% | -$6.49K | ﹤0.01% | 416 |
|
|
2020
Q4 | $7K | Hold |
191
| – | – | 0.01% | 281 |
|
|
2020
Q3 | $7K | Hold |
191
| – | – | 0.01% | 265 |
|
|
2020
Q2 | $7K | Buy |
191
+146
| +324% | +$5.35K | 0.01% | 258 |
|
|
2020
Q1 | $1K | Hold |
45
| – | – | ﹤0.01% | 320 |
|
|
2019
Q4 | $2K | Buy |
+45
| New | +$2K | ﹤0.01% | 338 |
|